Logos Global Management LP Design Therapeutics, Inc. Transaction History
Logos Global Management LP
- $756 Million
- Q3 2024
A detailed history of Logos Global Management LP transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 4,217,627 shares of DSGN stock, worth $23.1 Million. This represents 3.0% of its overall portfolio holdings.
Number of Shares
4,217,627
Previous 5,032,501
16.19%
Holding current value
$23.1 Million
Previous $16.9 Million
34.59%
% of portfolio
3.0%
Previous 1.58%
Shares
5 transactions
Others Institutions Holding DSGN
# of Institutions
102Shares Held
31MCall Options Held
2.3KPut Options Held
16.5K-
Sr One Capital Management, LP6.53MShares$35.8 Million11.88% of portfolio
-
Black Rock Inc. New York, NY2.3MShares$12.6 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.89MShares$10.4 Million0.55% of portfolio
-
Baker Bros. Advisors LP New York, NY1.74MShares$9.56 Million0.1% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.6MShares$8.77 Million0.02% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $306M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...